The Whitehead checklist defines "naive" cultured human embryonic stem cells, early flexible cells that can mature into almost any cell type and resemble early-embryo cells more than standard lab cells. It says to track transposable-element activity, ask whether cells match cleavage-stage embryos on three measures, and verify specific molecular and functional signs. Researchers from Rudolf Jaenisch's lab, Didier Trono's lab at EPFL, and Joseph Ecker's lab at Salk built the checklist together, according to the Whitehead Institute announcement. The work was published online in Cell Stem Cell.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does naive mean?
- What should labs track?
- How close is close to an embryo?
- How is a naive claim verified?
- What limit should readers remember?
What does naive mean?
Naive means preimplantation-like. Primed means postimplantation-like.
Naive cells are closer to the pluripotent cells of the early embryo. NIH and PMC authors report that naive cells offer higher developmental plasticity and more unbiased differentiation than primed cells. Validated naive lines are therefore a better model for development and future therapies.
What should labs track?
The team compared transposable-element profiles to judge naiveté. The Whitehead Institute reports the human genome holds about four million transposable elements versus about 25,000 genes.
A sharper signature is active transcription of HERVK/LTR5Hs and SVA_D elements, described as hallmarks that separate naive from primed cells in the UC review of Theunissen work. Ask whether a lab measured these elements, not only familiar marker genes.
How close is close to an embryo?
Ask whether cells match cleavage-stage embryos on three axes: gene expression, DNA methylation, and X-chromosome inactivation. Jaenisch said this match defines the naive state as very close to the human cleavage-stage embryo. For a skincare or clinic claim, translate that into plain questions.
What embryo-stage data support the label. Which of the three measures were tested. How large was the difference from the starting primed cells.
How is a naive claim verified?
Verification needs both molecular change and functional behavior. The checklist looks for reversible shifts in cell state, not one marker alone.
These criteria are listed in the Cell Stem Cell paper by Theunissen and colleagues. The morula test asks whether human cells can join very early mouse embryos, a strict plasticity check.
- Reversible global DNA demethylation
- Naive-like X-chromosome status
- Incorporation of naive human cells into mouse morulae in chimera assays
What limit should readers remember?
Most published "naive" protocols were judged unconvincing because the products stayed transcriptionally very similar to the starting primed cells, with little gene-expression difference, according to Jaenisch in the Newswise report. A new medium or brand name did not make cells naive.
So treat "naive" or "embryonic-like" on a product page as a lab claim that needs those three embryo measures and the functional tests above. Without that evidence, assume the cells are still primed.